IV tissue plasminogen activator (tPA) is a safe and effective therapy for acute ischemic stroke when administered within established time windows. The main complication from administration of tPA is ...

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both ...

In a study that included more than 71,000 stroke patients, implementation of a quality initiative was associated with improvement in the time to treatment and a lower risk of in-hospital death, ...

May 24, 2012 — Patients with acute ischemic stroke who are receiving warfarin can safely receive intravenous (IV) tissue plasminogen activator (tPA) if their international normalized ratio (INR) is ...

TISSUE PLASMINOGEN ACTIVATOR (TPA) INJECTED INTRAVENOUSLY within 3 hours of symptom onset has emerged as a treatment option for acute ischemic stroke. Although controversial and not universally ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Treatment of stroke with tissue plasminogen activator within 4.5 hours of stroke onset reduces ...

The use of a potentially lifesaving, clot-busting drug -- called tissue plasminogen activator (tPA) -- to treat patients with ischemic stroke nearly doubled between 2003 and 2011, according to a large ...

A nationwide program to promote the timeliness of intravenous (IV) tissue plasminogen activator (tPA) therapy for patients with acute ischemic stroke has borne fruit, according to a paper published in ...

Only a third of patients with acute stroke who receive intravenous tissue plasminogen activator (tPA) within 3 h of stroke onset achieve complete recanalization. One reason for a poor response to tPA ...

For patients who present to a thrombectomy-capable center, a direct trip to endovascular therapy does not improve functional outcomes compared with the guideline-recommended approach of giving IV ...

CINCINNATI--The University of Cincinnati (UC) Academic Health Center has received $17.4 million from the National Institutes of Health (NIH) to coordinate a five-year, international study of ...